Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Shares Rise, Sequenom Pulls Back

Shares of Agilent Technologies rose 7.7 percent for the five-day trading period ended Tuesday. Last week, the firm posted strong revenue gains for its Bio-Analytical Measurement segment, driven primarily by strong sales to life science customers (see related article).
 
In a generally down week for the stock market, Sequenom led decliners in the BCW Index for the tracking period. The firm’s shares fell 11.1 percent after recent gains pushed its shares up sharply.
 
Overall, the Index declined 1 percent for the week. In comparison, the Dow Jones Industrial Average dropped 2.2 percent, the Nasdaq fell 2.9 percent, and the Nasdaq Biotech Index declined 2.3 percent.
 
 

BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(November 20, 2007)
Last
Price
(November 13, 2007)
% change
Affymetrix
AFFX
20.62 21.67 -4.85
Agilent
A
36.51 33.91 7.67
Applied Biosystems
ABI
33.54 34.01 -1.38
Beckman
BEC
70.36 70.42 -0.09
Becton Dickinson
BDX
84.33 83.02 1.58
Bio-Rad
BIO
102 106.57 -4.29
Bruker
BRKR
9.12 9.74 -6.37
Caliper
CALP
5.32 5.21 2.11
Cepheid
CPHD
20.47 22.45 -8.82
Illumina
ILMN
51.25 53.06 -3.41
Invitrogen
IVGN
91.81 88.4 3.86
Luminex
LMNX
15.1 16.05 -5.92
MDS
MDZ
20.39 20.98 -2.81
Millipore
MIL
81.16 82.43 -1.54
PerkinElmer
PKI
26.76 27.03 -1.00
Qiagen
QGEN
20.31 21.7 -6.41
Sequenom
SQNM
8.83 9.93 -11.08
Sigma-Aldrich
SIAL
50.82 52 -2.27
Thermo
TMO
57.48 57.89 -0.71
Third Wave
TWTI
8 8.43 -5.10
Waters
WAT
76.79 74.96 2.44
BCW Index Average 42.43 42.85 -0.99
The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.